Search by Drug Name or NDC

    NDC 00006-5367-07 STEGLUJAN 5; 100 mg/1; mg/1 Details

    STEGLUJAN 5; 100 mg/1; mg/1

    STEGLUJAN is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Merck Sharp & Dohme LLC. The primary component is ERTUGLIFLOZIN PIDOLATE; SITAGLIPTIN PHOSPHATE.

    Product Information

    NDC 00006-5367
    Product ID 0006-5367_21cf231e-a04e-4f5b-82ab-b872482550f9
    Associated GPIs 27996502350320
    GCN Sequence Number 078036
    GCN Sequence Number Description ertugliflozin/sitagliptin phos TABLET 5 MG-100MG ORAL
    HIC3 C4W
    HIC3 Description ANTIHYPERGLYCEMIC, SGLT-2 AND DPP-4 INHIBITOR COMB
    GCN 44237
    HICL Sequence Number 044706
    HICL Sequence Number Description ERTUGLIFLOZIN PIDOLATE/SITAGLIPTIN PHOSPHATE
    Brand/Generic Brand
    Proprietary Name STEGLUJAN
    Proprietary Name Suffix n/a
    Non-Proprietary Name ertugliflozin and sitagliptin
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 5; 100
    Active Ingredient Units mg/1; mg/1
    Substance Name ERTUGLIFLOZIN PIDOLATE; SITAGLIPTIN PHOSPHATE
    Labeler Name Merck Sharp & Dohme LLC
    Pharmaceutical Class Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA209805
    Listing Certified Through 2024-12-31

    Package

    NDC 00006-5367-07 (00006536707)

    NDC Package Code 0006-5367-07
    Billing NDC 00006536707
    Package 500 TABLET, FILM COATED in 1 BOTTLE (0006-5367-07)
    Marketing Start Date 2017-12-19
    NDC Exclude Flag N
    Pricing Information N/A